Cargando…
A Recombinant RBD-Based Phage Vaccine Report: A Solution to the Prevention of New Diseases?
The safety, inherent immunogenicity, stability, and low-cost production of bacteriophages make them an ideal platform for vaccine development. Most vaccination strategies against COVID-19 have targeted the spike protein of SARS-CoV-2 to generate neutralizing antibodies. P1, a truncated RBD-derived s...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10144462/ https://www.ncbi.nlm.nih.gov/pubmed/37112745 http://dx.doi.org/10.3390/vaccines11040833 |